Neurones SA
PAR:NRO
Profitability Summary
Neurones SA's profitability score is 60/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
Score
Margins
Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.
Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Earnings Waterfall
Neurones SA
|
Revenue
|
774.9m
EUR
|
|
Cost of Revenue
|
-722k
EUR
|
|
Gross Profit
|
774.2m
EUR
|
|
Operating Expenses
|
-700.6m
EUR
|
|
Operating Income
|
73.6m
EUR
|
|
Other Expenses
|
-25.1m
EUR
|
|
Net Income
|
48.5m
EUR
|
Margins Comparison
Neurones SA Competitors
| Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|---|
| FR |
|
Neurones SA
PAR:NRO
|
1.2B EUR |
100%
|
9%
|
6%
|
|
| US |
|
International Business Machines Corp
NYSE:IBM
|
225.6B USD |
57%
|
16%
|
10%
|
|
| IE |
|
Accenture PLC
NYSE:ACN
|
190.7B USD |
32%
|
15%
|
11%
|
|
| IN |
|
Tata Consultancy Services Ltd
NSE:TCS
|
13T INR |
96%
|
25%
|
19%
|
|
| IN |
|
Infosys Ltd
NSE:INFY
|
6.5T INR |
30%
|
21%
|
17%
|
|
| IN |
|
HCL Technologies Ltd
NSE:HCLTECH
|
4.3T INR |
85%
|
18%
|
15%
|
|
| US |
|
Cognizant Technology Solutions Corp
NASDAQ:CTSH
|
37.6B USD |
34%
|
15%
|
11%
|
|
| JP |
|
Fujitsu Ltd
TSE:6702
|
5.6T JPY |
32%
|
6%
|
8%
|
|
| US |
|
Gartner Inc
NYSE:IT
|
32.4B USD |
68%
|
19%
|
20%
|
|
| IN |
|
Wipro Ltd
NSE:WIPRO
|
2.7T INR |
30%
|
17%
|
14%
|
|
| FR |
|
Capgemini SE
PAR:CAP
|
24.7B EUR |
27%
|
11%
|
8%
|
Return on Capital
Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.
Return on Capital Comparison
Neurones SA Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Neurones SA
PAR:NRO
|
1.2B EUR |
14%
|
7%
|
17%
|
22%
|
|
| US |
|
International Business Machines Corp
NYSE:IBM
|
225.6B USD |
24%
|
4%
|
9%
|
9%
|
|
| IE |
|
Accenture PLC
NYSE:ACN
|
190.7B USD |
27%
|
14%
|
27%
|
18%
|
|
| IN |
|
Tata Consultancy Services Ltd
NSE:TCS
|
13T INR |
49%
|
31%
|
57%
|
49%
|
|
| IN |
|
Infosys Ltd
NSE:INFY
|
6.5T INR |
33%
|
21%
|
35%
|
23%
|
|
| IN |
|
HCL Technologies Ltd
NSE:HCLTECH
|
4.3T INR |
25%
|
18%
|
28%
|
23%
|
|
| US |
|
Cognizant Technology Solutions Corp
NASDAQ:CTSH
|
37.6B USD |
16%
|
12%
|
19%
|
14%
|
|
| JP |
|
Fujitsu Ltd
TSE:6702
|
5.6T JPY |
19%
|
9%
|
11%
|
12%
|
|
| US |
|
Gartner Inc
NYSE:IT
|
32.4B USD |
123%
|
15%
|
27%
|
19%
|
|
| IN |
|
Wipro Ltd
NSE:WIPRO
|
2.7T INR |
16%
|
10%
|
16%
|
16%
|
|
| FR |
|
Capgemini SE
PAR:CAP
|
24.7B EUR |
15%
|
7%
|
14%
|
11%
|
Free Cash Flow
Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.
If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.
You don't have any saved screeners yet
